Biotechnology And Safety Assessment: 1st Edition (Hardback) book cover

Biotechnology And Safety Assessment

1st Edition

Edited by J A Thomas

CRC Press

637 pages

Purchasing Options:$ = USD
Hardback: 9781560327219
pub: 1998-11-17

FREE Standard Shipping!


This updated text explains how advances in mammalian and plant genetics contribute to better therapeutics agents and more wholesome foods. It addresses such topics as new pharmaceutical agents, agribiotechnology, safety evaluation of biotechnology-derived drugs, food safety, nutritional science, and regulatory and environmental aspects of genetically-modified organisms. New to this edition are chapters on biotherapeutics and herbicide-resistant crops. It should be of interest to biotechnology, toxicologists, pharmaceutical scientists, environmental scientists and agriculturists.

Table of Contents

1. Genomic Information - Frontiers of Toxicology J. Beall and M. Stodolsky 2. Antisense Therapeutics S. Crooke 3. Safety Evaluation of Food Crops Developed Through Biotechnology B. Hammond and R. Fuchs 4. Therapeutic Manipulation of Cytokines R. House 5. Triplex and Ribozyme Technology in Gene Repression Y. Lavrovsky, S. Chen and A. Roy 6. Food Allergens - Implications for Biotechnology S. Lehrer and G. Reese 7. The Pharmacokinetics and Toxicity of Phosphorothioate Oligonucleotides A. Levin, R. Geary, J. Leeds, D. Monteith, R. Yu, M. Templin, S. Henry 8. Biotechnology in Agriculture and the Environment - Benefits and Risks C. McCullum, D. Pimentel, M. Paoletti 9. Biotechnology and Risk H. Miller 10. Safety Assessment of Insect-Protected Corn P. Sanders, T. Lee, M. Groth, J. Astwood, R. Fuchs 11. Pharmacology of Recombinant Proteins J. Talmadge 12. Biotechnology - Therapeutic and Nutritional Products J. Thomas 13. Clinical Toxicity of Interferons T. Vial and J. Descotes. of Energy, S. Chen, University of Texas Health Science Centre, USA, S. Crooke, Isis Pharmaceuticals, USA, J. Descotes, Claude Bernard University, France, R. Fuchs, Monsanto, USA, R. Geary, Isis Pharmaceuticals, USA, M. Groth, Monsanto, USA, B. Hammond, Monsanto, USA, S. Henry, Isis Pharmaceuticals, USA, R. House, IIt Research, USA, Y. Lavrovsky, University of Texas Health Science Centre, USA, T. Lee, Monsanto, USA, J. Leeds, Isis Pharmaceuticals, USA, S. Lehrer, Tulane University Medical Centre, USA, A. Levin, Isis Pharmaceuticals, USA, C. McCullum, Cornell University, USA, H. Miller, Stanford University, USA, D. Monteith, Isis Pharmaceuticals, USA, M. Paoletti, Padova University, Italy, D. Pimentel, Cornell University, USA, G. Reese, Tulane University Medical Centre, USA, A. Roy, University of Texas Health Science Centre, USA, P. Sanders, Monsanto, USA, M. Stodolsky, US Department of Energy, J. Talmadge, University of Nebraska Medical Centre, USA, M. Templin, Isis Pharmaceuticals, USA, J. Thomas, University of Texas Health Science Centre, USA, T. Vial, Claude Bernard University, France, R. Yu, Isis Pharmaceuticals, USA.

Subject Categories

BISAC Subject Codes/Headings:
MEDICAL / Biotechnology